ArticleThe Journal of clinical investigation2023

Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.

Masaki Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.